FORMULATION DEVELOPMENT AND EVALUATION OF CALCIPOTRIOL AND PREDNICARBATE FOR TOPICAL TREATMENT OF PSORIASIS

Authors

  • Jyoti Phatangare Department of Pharmacy, Shree JJT University, Jhunjhunu, India

Abstract

Calcipotriol and Prednicarbate are widely used effective treatments for psoriasis vulgaris. Combined therapy is known to be superior to monotherapy, but the drug substance degrades when mixed together. The purpose of the study was to develop a formulation which combines Calcipotriol and Prednicarbate in a single vehicle hereby with optimal drug delivery into the skin. As the two substances are incompatible in aqueous and alcoholic medias, different non-aqueous formulations were prepared with suitable solvents and antioxidants. Formulations based on DPPG had no overall effect on skin permeability. However, A 5% polyoxypropylene-15 stearyl ether (PSE) formulation had a marked effect, resulted in a permeation rate comparable to the marketed combination product Diavobet (Calcipotriol and Betamethasone ointment). Thus, by using PSE as solvent, it was possible to combine Calcipotriol and Prednicarbate in a single formulation.

 

Keywords: Calcipotriol, Prednicarbate, polyoxypropylene-15 stearyl ether, psoriasis vulgaris.

DOI

https://doi.org/10.22270/jddt.v4i5.944

Published

2014-09-14
Statistics
Abstract Display: 941
PDF Downloads: 2369

How to Cite

1.
Phatangare J. FORMULATION DEVELOPMENT AND EVALUATION OF CALCIPOTRIOL AND PREDNICARBATE FOR TOPICAL TREATMENT OF PSORIASIS. J. Drug Delivery Ther. [Internet]. 2014 Sep. 14 [cited 2026 Jan. 22];4(5):109-15. Available from: https://jddtonline.info/index.php/jddt/article/view/944

How to Cite

1.
Phatangare J. FORMULATION DEVELOPMENT AND EVALUATION OF CALCIPOTRIOL AND PREDNICARBATE FOR TOPICAL TREATMENT OF PSORIASIS. J. Drug Delivery Ther. [Internet]. 2014 Sep. 14 [cited 2026 Jan. 22];4(5):109-15. Available from: https://jddtonline.info/index.php/jddt/article/view/944